BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Up 164.6% in December

BioNexus Gene Lab Corp. (NASDAQ:BGLC) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 197,100 shares, a growth of 164.6% from the November 30th total of 74,500 shares. Approximately 1.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 602,900 shares, the short-interest ratio is presently 0.3 days.

BioNexus Gene Lab Price Performance

Shares of BGLC stock opened at $0.27 on Friday. The firm has a 50-day moving average price of $0.31 and a 200 day moving average price of $0.40. BioNexus Gene Lab has a twelve month low of $0.21 and a twelve month high of $3.39.

BioNexus Gene Lab Company Profile

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.